SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.00-1.0%3:18 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject9/13/2000 12:21:12 AM
From: greedsgd_2000  Read Replies (2) of 52153
 
GEORGE GILDER AND THE BIOCOSM - now looks like a Gilder team will soon be focused on biotechs. It may take awhile but its on the burner. To understand potential valuation effects, you might want to look at some POWERCOSM stocks over the past 6 months - as a Gilder team focused on that sector recently. Of course, we all are familiar with THE TELECOSM - its the key focal point for the whole sector.

This is very good news going forward, and will guarantee renewed focus on biotechs.

Here is the Gildertech.com reference just posted:

posted to: Telecosm Lounge
poster: rgilder
date: 9/12/00 11:23:24 PM

--------------------------------------------------------------------------------

We will release further information in the future
regarding an upcoming Biotech newsletter. Right now
we are focusing on the products that we are unveiling at
Telecosm, but a biotech newsletter is in the works
though it will not be imminent.

Thanks,
Richard Gilder
Gilder Publishing, LLC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext